Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: Results of the ESTRON randomized phase 2 trial

Survival was similar for HFSRT and WBRT, while WBRT trended toward better ic-PFS. HFSRT showed substantially lower toxicity and better neurocognitive preservation, however, a higher risk of LMD. Risks and benefits should be weighed individually when determining post-operative treatment for BM.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-07-30
DOI
https://doi.org/10.1093/neuonc/noaf182
Citations
1
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: Results of the ESTRON randomized phase 2 trial

Rami A. El Shafie, Kristin Lang, Thomas Welzel, Farastuk Bozorgmehr et al.
1 citations
Neuro-Oncology
Brain Metastases and Treatment
1.52
article

Hypofractionated stereotactic radiotherapy versus whole-brain radiotherapy following brain metastasis resection: Results of the ESTRON randomized phase 2 trial

Rami A. El Shafie, Kristin Lang, Thomas Welzel, Farastuk Bozorgmehr, Daniela Schmitt, Laila König, Michael Thomas, Sinem Erdem, Meinhard Kieser, Cornelia Jäkel, Denise Bernhardt, Sebastian Adeberg, Stefan Rieken, Annabella Schiele, Fabian Weykamp, Tanja Eichkorn, Paul Thalmann, Jürgen Debus, Anja Sander, Adriane Lentz-Hommertgen, Angela Paul
article en
1 citations

Abstract

Survival was similar for HFSRT and WBRT, while WBRT trended toward better ic-PFS. HFSRT showed substantially lower toxicity and better neurocognitive preservation, however, a higher risk of LMD. Risks and benefits should be weighed individually when determining post-operative treatment for BM.

Neuro-OncologyVol. 27(12)
Philipps University of Marburg (DE), Zimmer Biomet (Netherlands) (NL), German Cancer Research Center (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), TUM Klinikum (DE), Zimmer Biomet (Germany) (DE), Heidelberger Institut für Radioonkologie (DE), National Center for Tumor Diseases (DE), Universitätsmedizin Göttingen (DE), German Center for Lung Research (DE), Deutsches Konsortium für Translationale Krebsforschung (DE)
Accuray
Good health and well-being
Openalex Percentile: Top 16%
Brain Metastases and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.